articleThe LancetMar 5, 2020BRONZE OA

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

ABAlison BirtleMJMark JohnsonJCJohn ChesterRJRobert J. JonesDDDavid Dolling

Lancashire Teaching Hospitals NHS Foundation Trust · University of Manchester · +15 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

524
total citations
FWCI
63.72
Percentile
100%
References
32
Citations per year

Authors

24

Topics & keywords

Topics
Keywords
  • Medicine
  • Open label
  • Adjuvant
  • Urothelial carcinoma
  • Adjuvant chemotherapy
  • Oncology
  • Chemotherapy
  • Internal medicine
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.

Funding